Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class I · High risk

Pink Bikini capsules

Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine, Phenolphthalein and/or Diclofenac.

Terminated Chemical / undeclared Lucy's Weight Loss (dba. Waisted With Lucy) D-0882-2016
Class I · High risk

LIPO ESCULTURA capsules

Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.

Terminated Chemical / undeclared Lipo Escultura Corp. D-0860-2016
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.

Terminated Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0519-2016
Class III · Low risk

Norpace CR

Failed Dissolution Specification

Terminated Dissolution failure Pfizer Inc. NDC 0025-2742-31 D-0520-2016
Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016
Class I · High risk

SUPER HERBS 350 mg

Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.

Terminated Chemical / undeclared Super Herbs D-0909-2016
Class III · Low risk

NABUMETONE Tablets USP

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Terminated Labeling / mix-up Teva Pharmaceuticals USA D-0773-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0555-0972-02 D-0566-2016
Class II · Moderate risk

tubby todd Bath Co

Microbial Contamination of Non-Sterile Products: Consumer complaint and subsequent testing found lot to be out of specification for mold.

Terminated Microbial contamination Mariposa Labs LLC D-0510-2019
Class II · Moderate risk

SyrSpend SF

Microbial Contamination of Non-Sterile Products: Syrspend SF and Syrspend SF Grape Flavor are being recalled due to the presence of yeast.

Terminated Microbial contamination Fagron, Inc NDC 51552-1079-9 D-0656-2016
Class II · Moderate risk

SyrSpend SF

Microbial Contamination of Non-Sterile Products: Syrspend SF and Syrspend SF Grape Flavor are being recalled due to the presence of yeast.

Terminated Microbial contamination Fagron, Inc NDC 51552-1167-9 D-0655-2016
Class II · Moderate risk

SyrSpend SF

Microbial Contamination of Non-Sterile Products: Syrspend SF and Syrspend SF Grape Flavor are being recalled due to the presence of yeast.

Terminated Microbial contamination Fagron, Inc NDC 51552-1079-5 D-0654-2016
Class II · Moderate risk

Rocuronium Bromide 50 MG/5ML INJ.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0222-57 D-0517-2016
Class II · Moderate risk

Novolin 70/30

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0414-01 D-0516-2016
Class II · Moderate risk

Lorazepam 2 mg/mL Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0316-01 D-0515-2016
Class II · Moderate risk

Ascorbic Acid 500 MG/ML Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0431-16 D-0514-2016
Class II · Moderate risk

Vitamin B-Complex 100

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0873-02 D-0513-2016
Class II · Moderate risk

Bicillin L-A 600000 Units/mL Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0253-03 D-0512-2016
Class II · Moderate risk

Humulin 70/30

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0415-08 D-0511-2016

Recalls by year